Sabra Healthcare REIT (NASDAQ:SBRA) Stock Rating Lowered by Truist Financial

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) was downgraded by analysts at Truist Financial from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, MarketBeat reports.

Other equities research analysts have also issued research reports about the company. Scotiabank dropped their price target on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Citigroup lowered shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and cut their price target for the company from $24.00 to $19.00 in a research note on Monday, June 22nd. UBS Group set a $19.00 price target on shares of Sabra Healthcare REIT in a report on Thursday, June 18th. Finally, Raymond James Financial initiated coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They set an “underperform” rating for the company. Five equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT presently has an average rating of “Hold” and a consensus price target of $21.27.

View Our Latest Report on SBRA

Sabra Healthcare REIT Stock Up 1.7%

Shares of NASDAQ SBRA opened at $20.06 on Wednesday. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $21.28. The stock’s fifty day simple moving average is $19.70 and its two-hundred day simple moving average is $19.68. The stock has a market capitalization of $5.06 billion, a PE ratio of 31.84, a price-to-earnings-growth ratio of 1.47 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Institutional Trading of Sabra Healthcare REIT

Several large investors have recently made changes to their positions in SBRA. Rothschild Investment LLC increased its stake in shares of Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares during the period. Smartleaf Asset Management LLC boosted its holdings in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the last quarter. Founders Capital Management acquired a new stake in Sabra Healthcare REIT during the 3rd quarter worth about $28,000. Strengthening Families & Communities LLC acquired a new stake in Sabra Healthcare REIT during the 4th quarter worth about $29,000. Finally, Versant Capital Management Inc raised its stake in shares of Sabra Healthcare REIT by 70.0% during the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 603 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Recommended Stories

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.